Details for Patent: 4,639,436

✉ Email this page to a colleague

Summary for Patent: 4,639,436

Patent landscape, scope, and claims:

Title:	Antidiabetic 3,4,5-trihydroxypiperidines
Abstract:	The invention includes certain 3,4,5-trihydroxypiperidine compounds, methods for their preparation, compositions containing said 3,4,5-trihydroxypiperidine compounds and methods for the use of said compounds and compositions. The subject matter of the invention is useful against diabetes, hyperlipaemia and adiposity as well as in animal nutrition.
Inventor(s):	Junge; Bodo (Wuppertal, DE), Krause; Hans P. (Wuppertal, DE), Muller; Lutz (Wuppertal, DE), Puls; Walter (Wuppertal, DE)
Assignee:	Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:	05/936,280
Patent Claim Types: see list of patent claims	Compound; Use; Composition; Formulation; Dosage form; Delivery;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 4,639,436

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 4,639,436

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	27387173	Aug 27, 1977
Germany	27580252	Dec 24, 1977

International Family Members for US Patent 4,639,436

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	373239	⤷ Subscribe
Austria	376420	⤷ Subscribe
Austria	376421	⤷ Subscribe
Austria	378771	⤷ Subscribe
Austria	A227183	⤷ Subscribe
Austria	A415383	⤷ Subscribe
Austria	A533181	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.